Get started
Author

Anna Hasegawa

Observed names: A. Hasegawa, Hasegawa, Anna
ORCID: 0009-0007-3667-2721
Observed ORCID: 0009-0007-3667-2721
OpenAlex ID: A5030198285
Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry
2024 · Yohei Kirino, Ayaka Maeda, et al. · Rheumatology · 29
PDF
Differences and similarities in cytokine profiles of macrophage activation syndrome in systemic lupus erythematosus and adult-onset Still’s disease
2023 · Tomoka Hiyama, Kazuhiro Kurasawa, et al. · Clinical and Experimental Medicine · 12
Clinical features and risk factors of flare in anti-synthetase syndrome
2025 · Anna Hasegawa, Kazuhiro Kurasawa, et al. · Clinical Rheumatology · 7
Pulmonary and serum cytokine profiles of patients with anti-ARS and anti-MDA5 antibodies
2025 · Kazuhiro Kurasawa, Satoko Arai, et al. · Journal of Autoimmunity · 5
Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study
2026 · Yohei Kirino, Ayaka Maeda, et al. · Annals of the Rheumatic Diseases · 4
Changing patterns of pulmonary abnormalities in rheumatoid arthritis
2022 · Ayae Tanaka, Kazuhiro Kurasawa, et al. · Respiratory Investigation · 4
Identifying two pathways to poor prognosis in patients with anti-MDA5 antibodies: insights from prognostic factor and cytokines analysis
2025 · Aya Shimizu, Kazuhiro Kurasawa, et al. · Arthritis Research & Therapy · 2
PDF
Developmental pathways of pulmonary abnormalities in rheumatoid arthritis according to sequential HRCT findings
2020 · Ayae Tanaka, Kazuhiro Kurasawa, et al. · 2
PDF
Pneumatosis intestinalis in a patient with anti-synthetase syndrome
2023 · Tomoka Hiyama, Anna Hasegawa, et al. · Oxford Medical Case Reports · 1
PDF
Single-cell analysis reveals transcriptomic patterns in active macrophage activation syndrome and therapeutic potential of albumin-fused interleukin-10 in a mouse model
2026 · Wataru Fujii, Hideaki Sofue, et al. · Frontiers in Immunology
PDF
Correction: Smartphone App–Based Eating Behavior Monitoring and Feedback Intervention for Glucocorticoid-Induced Appetite Increase in Patients With Systemic Lupus Erythematosus: Protocol for a Pilot Randomized Controlled Trial
2026 · Takashi Yamaguchi, Nobuyuki Takahashi, et al. · JMIR Research Protocols
A Case of IgG4 ‐Related Disease That Mimics an Anterior Mediastinal Malignant Tumour
2026 · Noriaki Nishimura, Yusuke Nakamura, et al. · Respirology Case Reports
PDF
Abs1161 Achieving Rapid and Sustained Remission After Starting Treatment With Molecular Targeting Drugs Prevents Worsening of Lung Lesions in Rheumatoid Arthritis
2025 · A. Tanaka, M. Suwa, et al. · Annals of the Rheumatic Diseases
Non-neutralizing Autoantibodies against Granulocyte-macrophage Colony-stimulating Factor in Patients with Systemic Lupus Erythematosus
2025 · Nagasawa, Junya, Kurasawa, Kazuhiro, et al. · Institutional Repositories DataBase (IRDB)
PDF
Anti-neutrophilic Antibody-positive Systemic Lupus Erythematosus with Acute Kidney Injury and Diffuse Alveolar Hemorrhage with Concomitant Coronavirus Disease 2019 (COVID-19)
2024 · Hasegawa, Anna, Hiyama, Tomoka, et al. · Institutional Repositories DataBase (IRDB)
Pos0408 Controlling Disease Activity With Biological Dmards Prevents Development/progression of Interstitial Lung Disease in Rheumatoid Arthritis
2024 · A. Tanaka, K. Kurasawa, et al. · Annals of the Rheumatic Diseases
Pos1283 Risk Factors for Flares in Anti-synthetase Syndrome: Clinical Features, Autoantibodies, and Treatment
2024 · A. Hasegawa, K. Kurasawa, et al. · Annals of the Rheumatic Diseases
Ab0307 Jak Inhibitors Do Not Worsen Ra-ild; Comparison of Changes in Ct Images and Kl-6/sp-d Levels Between Periods With Biologics and With Jak Inhibitors in the Same Individuals
2023 · A. Tanaka, R. Koike, et al. · Annals of the Rheumatic Diseases
PDF
Thu0153 Tcz Might Be a Risk Factor for Worsening of Ild, Particularly of Chronic Ild
2020 · A. Tanaka, T. Owada, et al. · Annals of the Rheumatic Diseases
PDF
Works count: 19
Citation count: 66
H-index: 4
I10-index: 2
Year
Topic
Type